NCT00006083 - Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter | Biotech Hunter

Timeline

Start Date

April 30, 2000

Primary Completion Date

November 30, 2000

Study Completion Date

November 30, 2000

Conditions

Cervical CancerChronic Myeloproliferative DisordersLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesPrecancerous/Nonmalignant ConditionUnspecified Adult Solid Tumor, Protocol SpecificVeno-occlusive Disease

Interventions

DRUG

Fragmin

Fragmin at 5000 IU injected subcutaneously daily

OTHER

placebo

placebo injected subcutaneously daily

Trial Locations (1)

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles